NewLink Genetics (NLNK:NAS) and Aquinox Pharmaceuticals (AQXP:NAS) Trading at Less than Cash Value

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
LEXEB Liberty Expedia Holdings Inc 48.050000 57276969 None 1.0939 55.75 -28.30
LEXEA Liberty Expedia Holdings Inc 41.730000 57276969 None 0.9500 55.75 -28.30
SOHU Sohu.com Ltd 16.830000 38916788 None 0.9859 29.71 23.98
PDLI PDL BioPharma Inc 2.540000 145400381 3.6029 0.5182 2.72 1.89
SCPH scPharmaceuticals Inc 4.420000 18569289 None 0.9265 5.43 4.91
OPHT Ophthotech Corp 2.260000 36198436 0.5305 4.6668 4.03 5.82
NLNK NewLink Genetics Corp 2.160000 37214286 None 0.6433 3.68 3.68
ACET Aceto Corp 2.150000 30787241 None 0.6947 3.28 -7.03
AQXP Aquinox Pharmaceuticals Inc 2.590000 23537368 None 0.6723 4.21 4.21
VVUS VIVUS Inc 4.100000 10622716 None None 5.38 -22.43
ARAV Aravive Inc 6.070000 6040124 None 0.5318 11.22 10.01
APWC Asia Pacific Wire & Cable Corp Ltd 2.400000 13819669 8.2759 0.2096 3.91 1.37
GIGM GigaMedia Ltd 2.980000 11052235 32.0000 0.5531 5.50 5.77
VXRT Vaxart Inc 3.230000 7141189 None 1.0319 3.35 2.72
ASNS Arsanis Inc 1.500000 14315410 None 0.5686 3.49 2.71
NVIV InVivo Therapeutics Holdings Corp 2.399600 7763420 None 1.8562 2.88 2.83
ABAC Renmin Tianli Group Inc 1.990000 7983745 24.8750 0.1783 7.87 7.61
CREG China Recycling Energy Corp 1.520000 8310198 None 0.0630 6.15 0.12
ACHV Achieve Life Sciences Inc 2.430000 4551005 0.0163 0.6726 3.36 0.92
ALQA Alliqua BioMedical Inc 2.040000 5005210 None 0.9938 2.20 -2.26
RTTR Ritter Pharmaceuticals Inc 1.680000 5534639 None 0.8711 2.94 None
KBSF KBS Fashion Group Ltd 3.760000 2206741 None 0.1151 10.93 10.21
ATOS Atossa Genetics Inc 1.500000 5500000 None 0.6081 2.77 1.43
JMU JMU Ltd 1.730000 819615 None 0.0620 13.11 3.53
RLM Realm Therapeutics PLC 2.900000 4662476 None 0.5569 3.48 2.74

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

NLNK:NAS NewLink Genetics

http://www.newlinkgenetics.com
NewLink Genetics has 76 employees and is headquartered in United States.
NewLink Genetics Corp is a clinical stage immuno-oncology company based in US. It focuses on developing novel immunotherapeutic products for the treatment of cancer. Its portfolio contains biologic and small-molecule immuno-oncology product candidates.

AQXP:NAS Aquinox Pharmaceuticals

http://www.aqxpharma.com
Aquinox Pharmaceuticals has 52 employees and is headquartered in Canada.
Aquinox Pharmaceuticals Inc is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.